A PHARMACOVIGILANCE STUDY TO ANALYZE THE ADVERSE DRUG REACTIONS IN PATIENTS TREATED WITH ANTIHYPERTENSIVE DRUG IN TERTIARY CARE TEACHING HOSPITALS
Main Article Content
Keywords
ADR, Pharmacovigilance, Hypertension, Antihypertensive Drugs, Efficacy and drug safety
Abstract
Introductions:- Hypertension is the most common cardiovascular disease and most important public health problem. Increased arterial pressure causes hypertrophy of the left ventricle leads to pathological changes in the vasculature. Pharmacovigilance analysis study provided an insight into the drug use pattern and rational use of drugs. The outcomes of the present study contribute to us as well as public knowledge about drugs effectiveness and theirs safety concern.
Material & Methods: This Pharmacovigilance analysis study was a Prospective and observational study conducted in Department of Pharmacology, Santosh Medical College and Hospital, Santosh Deemed To be University (SDTU), Ghaziabad in Collaboration with Department of Medicine, Muzaffarnagar Medical College, Muzaffarnagar during the period of June 2019 to December 2022. The study was approved by IEC, of Santosh Deemed to be University, Ghaziabad in 2019. The study was a part of PhD thesis of corresponding author. The Individual Data for Pharmacovigilance analysis was collected for 6 months of period with the help of ―Suspected Adverse Drug Reaction Reporting Form V. 1.3 and ―Medicines Side Effect Reporting Form (For Consumers) v.1.0. Statistical analysis was done by SPSS v- 20 and Excel-Sheet.
Results: A total of 242 Hypertensive patients following inclusion and exclusion criteria of both genders were observed in the study. Out of 242 patients a total 47 patients showed 25 types of ADRs were recorded and assessed for 6 months. Among 47 patients, the prevalence of ADRs was
predominantly higher in the patients having higher age group, i.e., > 40 years of age (70 %.). Compared to monotherapy (15-25%), combinational therapy (using more than one medicine) was linked to a higher proportion of adverse drug reactions (27.3-36.4%). The anti-hypertensive drugs combinations most frequently linked to ADRs were ARB+CCB+DU (36.36%), followed by CCB + BB (28.57%), ARB + CCB (27.27(19.35%), ACEI(25%), ARB + DU (16.67%), BB (15.15%) and ARB (15%).
Conclusion: The results of the above study would be useful for the physicians in rational selection of drug therapy for treatment of hypertensive patients. The present data suggest that the ADR monitoring needs to be done in hospital settings continuously so that untoward effect caused by different medicines can be identified and documented.
References
2. Franklin SS, et al. (1997). Hemodynamic patterns of age – related changes in blood pressure: the Framingham Heart Study, Circulation, 96,308-3015.
3. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, Hypertension, 2003, 42:1206-1252.
4. Neupane GP, Rai M. Adverse drug reaction profile and prescription pattern of antihypertensive drug monotherapy at tertiary care hospital Nepalgunj, Nepal. Int J Basic Clin Pharmacol 2018;7(1):75-9.
5. Olsen H, Klemetsrud T, Stokke HP, Tretlis T, Westheim A. Adverse drug reactions in current antihypertensive therapy: A general practice survey of 2586 patients in Norway. Blood Press 1999;8:94-101.
6. Wallander MA, Dimenas E, Svardsudd K, Wiklund I. Evaluation of three methods of symptom reporting in a clinical trial of felodipine. Eur J Clin Pharmacol 1991; 41:187-96.
7. Riley J, Wilton LV, Shakir SA. A post marketing observational study to assess the safety of mibefradil in the community of England. Int J Clin Pharmacol Ther 2002; 40:241-8.
8. Dhikav V, Singh S, Anand KS. Adverse drug reaction monitoring in India. J Indian Acad Clin Med 2004;5:27-3.
9. Parthasarathi G, Olsson S, Adverse drug reactions. In: Parthasarathi G, Nyfort-Hansen K, Nahata MC, editors. A textbook of clinical pharmacy practice, 1st ed. Chennai: Orient Longman Pvt Ltd; 2004. p. 84-102.
10. Garg KC, Singhal KC, Kumar S. Monitoring the adverse profile of atenolol a collaborative study. Indian J Physiol Pharmacol 1993; 37:213- 6.
11. Jose J, Rao GM. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res., 2006; 54: 226-33.
12. Kale S, Patil A, Mandlecha RH. Compliance and adverse drugs effects of Antihypertensives in rural India. 2011;5(4):775-9.
13. Giles TD, et al. Definition and classification of hypertension: An update. J Clin Hypertens. 2009; 11:611-614.
14. Rishi RK, Patel RK and Bhandari A: Under reporting of ADRs by medical practitioners in India—results of pilot study. Adv Pharmacoepidem Drug Saf 2012; 1(3): 112.
15. Güner MD and Ekmekci PE: Healthcare professionals' pharmacovigilance knowledge and adverse drug reaction reporting behaviour and factors determining the reporting rates. J Drug Assess 2019; 8(1): 13-20.
16. Kalaiselvan V, Kumar P, Mishra P and Singh GN: System of adverse drug reactions reporting: What, where, how, and whom to report? Indian J Crit Care Med 2015; 19(9): 564-6.
17. Amale PN, Deshpande SA, Nakhate YD and Arsod NA: Pharmacovigilance process in India: An overview. J Pharmacovigil 2018; 6(2): 259.
18. Alessandro Oteri, GiampieroMazzaglia, Serena Pecchioli, Mariam Molokhia, Sinna PilgaardUlrichsen, Lars Pedersen, Elisabetta Poluzzi, Fabrizio DE Ponti, EdeltrautGarbe, Tania Schink, Ron Herings, Irene D. Bezemer, Miriam C.J.M. Stturkenboom and Gianluca Trifiro: Prescribing pattern of antipsychotic drugs during the years 1996–2010: A population based database study in Europe with a focus on torsadogenic drugs. British Journal of Clinical Pharmacology 2016; 82(2): 487-497.
19. Steinman MA and Hanlon JT: Managing Medications in Clinically Complex Elders:- There's
Got to Be a Happy Medium‖. JAMA 2010; 304(14): 1592–1601.
20. Watson S, Caster O, Rochon PA and den Ruijter H: Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinical Medicine 2019; 17: 100188.
21. Soldin OP, Chung SH and Mattison DR: Sex differences in drug disposition. J Biomed Biotechnol 2011; 2011: 1-14.
22. Bassi PU, Osakwe AI, Ogar CK, Elagbaje C, Nwankwo BB,Balogun ST, Ntadom GN and Isah AO: Impact of comorbidity on adverse drug reaction profile in a cohort of patients treated with Artemisinin combination therapies for uncomplicated malaria in Nigeria. Pharmacol Res Perspect 2017; 5(2): 1-8
23. Committee G. 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. Journal of hypertension. 2003;21(6):1011- 53.
24. Olsen H, Klemetsrud T, Stokke HP, Tretli S, Westheim A. Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway. Blood Pressure. 1999;8(2):94-101
25. Committee G. 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. Journal of hypertension. 2003;21(6):1011- 53.
26. Olsen H, Klemetsrud T, Stokke HP, Tretli S, Westheim A. Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway. Blood Pressure. 1999;8(2):94-101.
27. Paudel S, Chetty MS, Laudari S, Subedi N. Adverse drug reactions of antihypertensive agents at tertiary care hospital in central Nepal. Journal of College of Medical Sciences- Nepal. 2017;13(2):284-9
28. Khurshid F, Aqil M, Alam MS, Kapur P, Pillai KK. Monitoring of adverse drug reactions associated with antihypertensive medicines at a university teaching hospital in New Delhi. DARU Journal of Pharmaceutical Sciences. 2012; 20(1):1-6.
29. Basak S, Ravi K, Manavalan R, Sahoo K. A study of adverse drug reactions to antihypertensive drugs perceived by patients in a rural hospital. Indian journal of pharmaceutical sciences. 2004; 66(6):814-18.
30. Jose J, Rao GM. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 2006; 54:226-33.
31. Aellig HW. Adverse reactions to antihypertensive therapy. Cardiovas Drug Ther 1998; 12:189- 96.
32. Aqil M, Imam F, Hussain A, Alam MS, Kapur P, Pillai KK. A pharmacovigilance study for monitoring adverse drug reactions with antihypertensive agents at a South Delhi hospital. Int J Pharm Pract 2006; 14:311-3.
33. Jamunarani R and Priya M: Analysis of Adverse Drug Reaction Related hospital admissions and Common Challenges Encountered in ADR reporting in a Tertiary Care Teaching Hospital. Asian Journal of Pharmaceutical and Clinical Research 2014; 7(1): 141-143.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Lalendra Yadav
Assistant Professor, Department of Pharmacology, Government Medical College, Budaun, Uttar Pradesh
Shaktibala Dutta
Professor & HOD, Department of Pharmacology, Graphic Era Institute of Medical Science (GEIMS), Dehradun, Uttrakhand.
Jyotsna Sharma
Professor & HOD, Department of Pharmacology (GS Medical College, Pilkhuwa, Hapur), Uttar Pradesh.
Rajni Kumari Rai
Assistant Professor, Department of Pharmacology, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh
Prithpal Singh Matreja
Professor & HOD, Department of Pharmacology, Teerthanker Mahaveer Medical College & Research Center, TMU, Moradabad, Uttar Pradesh
Ila Pahwa
Professor Department of Medicine, Muzaffarnagar Medical College, Muzaffarnagar, Uttar Pradesh.